Eculizumab decreases the procoagulant activity of extracellular vesicles in paroxysmal nocturnal hemoglobinuria: A pilot prospective longitudinal clinical study. [electronic resource]
- Thrombosis research Aug 2017
- 142-148 p. digital
Publication Type: Journal Article
1879-2472
10.1016/j.thromres.2017.06.013 doi
Antibodies, Monoclonal, Humanized--administration & dosage Female Hemoglobinuria, Paroxysmal--blood Humans Longitudinal Studies Male Middle Aged Pilot Projects Prospective Studies